ALFA Finder| Revenue growth | Core revenue grew 33% YoY after exiting low-margin trading segments. |
|---|---|
| Margins | Margins contracted sharply to 23.7% due to own-brand inventory shortages. |
| Demand visibility | Strong structural demand in under-served Tier 2 and Tier 3 cities. |
| Management confidence | Humble and defensive, admitting significant operational errors in supply chain. |
Growth
Core revenue grew 33% YoY; however, margins compressed from 34% to 23.7% due to own-brand stockouts.
Outlook
Management aims to double revenue every 3-4 years and return EBITDA to mid-teens.
Risks
Significant supply chain vulnerability and reliance on a weaker rupee increasing imported product costs.
Earnings Call filed with NSE, NSE: DENTALKART. Summary written with AI assistance from the document.
Vasa Denticity Ltd: key numbers
- Share price
- ₹459.60
- Market cap
- ₹763.9 Cr
- Revenue (annual)
- ₹278.9 Cr
- Net profit (annual)
- ₹10.24 Cr
- P/E (TTM)
- 74.6×Sector 54.5×
- Promoter holding
- 59.65%-0.54% QoQ
- FII holding
- 7.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vasa Denticity Ltd
All →Vasa Denticity Earnings Call Transcript: Key Takeaways
Revenue up 19.4% to ₹87.1 Cr; EBITDA ₹7.24 Cr, margin 8.31% vs 8.01%. Margin gain driven by opex cut; gross margin fell ~6 pts amid stock rebuild.
Vasa Denticity Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹87.10 Cr (+19.4% YoY), PAT ₹5.20 Cr (+8.8%), Op. EBITDA ₹7.24 Cr (+23.9%, 8.3% margin). Margin recovery driven by lower operating costs, not gross margin.
Vasa Denticity Management Change
Vasa Denticity re-appointed Independent Director Varun Chugh for five years, effective November 6, 2026. Shareholder approval at a general meeting is pending.
- Execution
- November 6, 2026 to November 6, 2031
Vasa Denticity Q2 FY27 Results: Net Profit ₹5.2 Cr, Up 8.3% YoY
Vasa Denticity Ltd reported revenue from operations of ₹87.1 Cr (+19.5% YoY) and net profit of ₹5.2 Cr (+8.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹5.2 Cr · +8.3% YoY
Vasa Denticity Board Meeting Date
VASA Denticity Limited will hold a board meeting on 06-Nov-2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closure is in effect from 01-Oct-2026.
Vasa Denticity Convertible Warrants
Vasa Denticity received NSE trading approval for 1,50,000 shares from preferential warrant conversion. Listed capital rises to ₹17.49 crore, with trading from 02 November 2026.